Ken Duncan
GlaxoSmithKline
Gunnels Wood Road
Stevenage SG1 2NY
UK
Name/email consistency: high
- Prospects for new antitubercular drugs. Duncan, K., Barry, C.E. Curr. Opin. Microbiol. (2004)
- Identification and validation of novel drug targets in tuberculosis. Duncan, K. Curr. Pharm. Des. (2004)
- Progress in TB drug development and what is still needed. Duncan, K. Tuberculosis. (Edinb) (2003)